Stavudine-containing regimens have also been previously shown to be associated with hyperlipidemia, through a mechanism involving mitochondrial respiratory chain dysfunction and reduced SREBPs and adiponectin levels [54]. The gene discussed is ADIPOQ; the disease is hyperlipidemia.